Where does 23andMe, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), 23andMe, Inc. ranks #3,442 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does 23andMe, Inc. hold?

23andMe, Inc. holds 107 US utility patents granted between 2015 and 2025, spanning 15 technology areas.

What is 23andMe, Inc.'s Innovation Score?

23andMe, Inc. has an Innovation Score of 49.3 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is 23andMe, Inc.'s patent grant rate increasing or decreasing?

23andMe, Inc.'s recent grant velocity is +226% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for 23andMe, Inc.'s patents?

23andMe, Inc.'s patents average 17.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the 23andMe, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

23andMe, Inc.

Q: What technology areas does 23andMe, Inc. focus on?

23andMe, Inc.'s top technology area is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology) with 77 patents, ranking #7 of 676 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

USPTO PatentsView assignee record - 107 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, 23andme ranks #3,442 of 49,997 tracked US assignees by granted-patent volume, with 107 patents across 15 technology areas.

#3,442
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.3/100): 17.9
avg claims per patent: +226%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3442 · US Corporation #3,442 · 107 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 107 grants
TOP-DECILE #3,442/49,997
PHOTO-FINISH AmTRAN Technology
CPC-FOCUS G16B · 15 areas
INNOV-PAR 49.3/100
CLAIMS-RICH 17.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +226% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AmTRAN Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How 23andme’s 49.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.2 pts (33%) Velocity 8.8 pts (18%) Breadth 13.7 pts (28%) Claim depth 10.7 pts (22%)

Qualcomm Incorporated · highest

85
23andMe · this assignee

49
Alps Electric · near

49
National University… · near

49
Neuravi · near

49
Newport Fab · near

49
3D Lighting… · lowest

7

What this shows 23andme's Innovation Score is 49.3/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for 23andme?

Each dot is one of 23andme’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). 23andme’s own 17.9 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

23andme vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where 23andme's grants concentrate

23andMe, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 72% of grants classified under G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology). Peak complete grant year is 2023 (18 grants) versus a trough of 3 in 2016. By volume, 23andme sits between Toshiba Solutions Corporation and Bestop, Inc..

23andme's three-year grant acceleration

From 2019–2021 to 2022–2024, 23andMe, Inc. moved from 35 to 46 grants (1.31x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #628. See the growth leaderboard.

Toshiba Solutions

108
U S Well Services

108
Walbro

108
WCM Industries

108
Amtran Technology

107
Aurora Labs

107
BCE

107
Bestop

107
23andme ◀

107

What this shows 23andMe holds 107 patents at rank #3,442, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 23andMe

By rank, the assignees closest to #3,442 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in 23andMe's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for 23andMe, neither rank-band nor same-CPC leaders (those blocks stay above). In G16B (Bioinformatics), 23andMe ranks #7 of 676 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

Neuravi Limited 49 Newport Fab, LLC 49 National University Corporation Okayama University 49 Alps Electric Co., Ltd. 49

Similar claim depth

Nearest assignees by average claims per patent (17.9 here).

The University Of North Carolina At Charlotte 17.9 avg Galapagos NV 17.9 avg Xintec Inc. 17.9 avg Inguran, LLC 17.9 avg

23andme's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

23andMe, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	4.7%
2016	3	2.8%
2017	5	4.7%
2018	4	3.7%
2019	6	5.6%
2020	14	13.1%
2021	15	14.0%
2022	17	15.9%
2023	18	16.8%
2024	11	10.3%
2025partial year	9	8.4%

Which technologies does 23andMe, Inc. patent most?

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 77

G06F - Electric Digital Data Processing 61

G06N - Computing Arrangements Based ON Specific Computational Models 46

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 35

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 23

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 15

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 15

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

C07K - Peptides 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

G06T - Image Data Processing OR Generation, IN General 2

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

23andMe, Inc.'s patent record in context - here's where to go next.

23andMe, Inc.'s lead technology class is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology), 72% of its portfolio - see every assignee active in that class. Explore G16B
Ranked #3,442 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare 23andMe, Inc. against Toshiba Solutions Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.